Use this url to cite publication: https://hdl.handle.net/20.500.12512/23242
Cancer antigen 125: lost to follow-up?: a European society of gynaecological oncology consensus statement
Type of publication
Straipsnis Web of Science duomenų bazėje / Article in Web of Science database (S1a)
Author(s)
Author(s) | |
---|---|
Verheijen, Rene | University Medical Centre Utrecht, Utrecht, The Netherlands |
Cibula, David | Gynaecologic Oncology Centre, Department of Obstetrics and Gynaecology, General University Hospital, First Medical School, Charles University, Prague, Czech Republic |
Zola, Paolo | Department of Gynaecologic Oncology Ospedale Mauriziano “Umberto I,” Turin, Italy |
Reed, Nicholas | Beatson Oncology Center, Gartnavel General Hospital, Glasgow, UK |
van der Zee, AG | European Society of Gynaecological Oncology, Geneva, Switzerland |
Colombo, Nicoletta | European Society of Gynaecological Oncology, Geneva, Switzerland |
Gitsch, Gerald | European Society of Gynaecological Oncology, Geneva, Switzerland |
Amant, Frédéric | European Society of Gynaecological Oncology, Geneva, Switzerland |
Kesic, Vesna | European Society of Gynaecological Oncology, Geneva, Switzerland |
Kimmig, Rainer | European Society of Gynaecological Oncology, Geneva, Switzerland |
Lopes, Alberto | European Society of Gynaecological Oncology, Geneva, Switzerland |
Markowska, Janina | |